Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
-0.27% $11.14
America/New_York / 20 nov 2023 @ 09:59
FUNDAMENTALS | |
---|---|
MarketCap: | 48.30 mill |
EPS: | -0.130 |
P/E: | -85.69 |
Earnings Date: | Mar 30, 2023 |
SharesOutstanding: | 4.34 mill |
Avg Daily Volume: | 0.0034 mill |
RATING 2023-11-28 |
---|
C+ |
Sell |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Sell | |
P/E: | Strong Sell | |
Price To Book: | Buy |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
1/22 | 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | ||||
Ebit | ||||||
Asset | ||||||
Debt | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -85.69 | sector: PE -18.15 |
PE RATIO: COMPANY / INDUSTRY |
---|
0x |
Company: PE -85.69 | industry: PE -25.74 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
$ 11.12 - 11.16 ( +/- 0.16%) |
ATR Model: 14 days |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-03-09 | Chardan Monterey Investments Llc | Buy | 478 125 | Common Stock |
2023-03-09 | Chardan Monterey Investments Llc | Sell | 13 125 | Common Stock |
2022-09-29 | Chardan Monterey Investments Llc | Sell | 0 | Common Stock |
2023-03-09 | Grossman Jonas | Buy | 478 125 | Common Stock |
2023-03-09 | Grossman Jonas | Sell | 13 125 | Common Stock |
INSIDER POWER |
---|
-5.75 |
Last 20 transactions |
Buy: 1 106 250 | Sell: 1 241 250 |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | $11.14 (-0.27% ) |
Volume | 0.0042 mill |
Avg. Vol. | 0.0034 mill |
% of Avg. Vol | 122.79 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Monterey Bio Acquisition Corporation does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the biotech industry. The company was formerly known as Chardan FinTech Acquisition Corp. and changed its name to Monterey Bio Acquisition Corporation in April 2021. Monterey Bio Acquisition Corporation was incorporated in 2020 and is based in New York, New York.